244 related articles for article (PubMed ID: 27122614)
21. Fragile X mental retardation protein participates in non-coding RNA pathways.
Li EH; Zhao X; Zhang C; Liu W
Yi Chuan; 2018 Feb; 40(2):87-94. PubMed ID: 29428901
[TBL] [Abstract][Full Text] [Related]
22. Quantitative profiling of brain lipid raft proteome in a mouse model of fragile X syndrome.
Kalinowska M; Castillo C; Francesconi A
PLoS One; 2015; 10(4):e0121464. PubMed ID: 25849048
[TBL] [Abstract][Full Text] [Related]
23. Tissue plasminogen activator contributes to alterations of neuronal migration and activity-dependent responses in fragile X mice.
Achuta VS; Rezov V; Uutela M; Louhivuori V; Louhivuori L; Castrén ML
J Neurosci; 2014 Jan; 34(5):1916-23. PubMed ID: 24478370
[TBL] [Abstract][Full Text] [Related]
24. Fragile x mental retardation protein regulates proliferation and differentiation of adult neural stem/progenitor cells.
Luo Y; Shan G; Guo W; Smrt RD; Johnson EB; Li X; Pfeiffer RL; Szulwach KE; Duan R; Barkho BZ; Li W; Liu C; Jin P; Zhao X
PLoS Genet; 2010 Apr; 6(4):e1000898. PubMed ID: 20386739
[TBL] [Abstract][Full Text] [Related]
25. Independent role for presynaptic FMRP revealed by an FMR1 missense mutation associated with intellectual disability and seizures.
Myrick LK; Deng PY; Hashimoto H; Oh YM; Cho Y; Poidevin MJ; Suhl JA; Visootsak J; Cavalli V; Jin P; Cheng X; Warren ST; Klyachko VA
Proc Natl Acad Sci U S A; 2015 Jan; 112(4):949-56. PubMed ID: 25561520
[TBL] [Abstract][Full Text] [Related]
26. Fragile X mental retardation protein knockdown in the developing Xenopus tadpole optic tectum results in enhanced feedforward inhibition and behavioral deficits.
Truszkowski TL; James EJ; Hasan M; Wishard TJ; Liu Z; Pratt KG; Cline HT; Aizenman CD
Neural Dev; 2016 Aug; 11(1):14. PubMed ID: 27503008
[TBL] [Abstract][Full Text] [Related]
27. Sumoylation regulates FMRP-mediated dendritic spine elimination and maturation.
Khayachi A; Gwizdek C; Poupon G; Alcor D; Chafai M; Cassé F; Maurin T; Prieto M; Folci A; De Graeve F; Castagnola S; Gautier R; Schorova L; Loriol C; Pronot M; Besse F; Brau F; Deval E; Bardoni B; Martin S
Nat Commun; 2018 Feb; 9(1):757. PubMed ID: 29472612
[TBL] [Abstract][Full Text] [Related]
28. FMRP(1-297)-tat restores ion channel and synaptic function in a model of Fragile X syndrome.
Zhan X; Asmara H; Cheng N; Sahu G; Sanchez E; Zhang FX; Zamponi GW; Rho JM; Turner RW
Nat Commun; 2020 Jun; 11(1):2755. PubMed ID: 32488011
[TBL] [Abstract][Full Text] [Related]
29. Fragile X Syndrome: from molecular pathology to therapy.
Maurin T; Zongaro S; Bardoni B
Neurosci Biobehav Rev; 2014 Oct; 46 Pt 2():242-55. PubMed ID: 24462888
[TBL] [Abstract][Full Text] [Related]
30. Matrix metalloproteinase-9 deletion rescues auditory evoked potential habituation deficit in a mouse model of Fragile X Syndrome.
Lovelace JW; Wen TH; Reinhard S; Hsu MS; Sidhu H; Ethell IM; Binder DK; Razak KA
Neurobiol Dis; 2016 May; 89():126-35. PubMed ID: 26850918
[TBL] [Abstract][Full Text] [Related]
31. Altered differentiation of neural stem cells in fragile X syndrome.
Castrén M; Tervonen T; Kärkkäinen V; Heinonen S; Castrén E; Larsson K; Bakker CE; Oostra BA; Akerman K
Proc Natl Acad Sci U S A; 2005 Dec; 102(49):17834-9. PubMed ID: 16314562
[TBL] [Abstract][Full Text] [Related]
32. Linking the Fragile X mental retardation protein to the lipoxygenase pathway.
Beaulieu MA
Med Hypotheses; 2013 Mar; 80(3):289-91. PubMed ID: 23313071
[TBL] [Abstract][Full Text] [Related]
33. Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function.
Bassell GJ; Warren ST
Neuron; 2008 Oct; 60(2):201-14. PubMed ID: 18957214
[TBL] [Abstract][Full Text] [Related]
34. Translational endpoints in fragile X syndrome.
de Esch CE; Zeidler S; Willemsen R
Neurosci Biobehav Rev; 2014 Oct; 46 Pt 2():256-69. PubMed ID: 24184744
[TBL] [Abstract][Full Text] [Related]
35. Deregulation of ER-mitochondria contact formation and mitochondrial calcium homeostasis mediated by VDAC in fragile X syndrome.
Geng J; Khaket TP; Pan J; Li W; Zhang Y; Ping Y; Cobos Sillero MI; Lu B
Dev Cell; 2023 Apr; 58(7):597-615.e10. PubMed ID: 37040696
[TBL] [Abstract][Full Text] [Related]
36. Synaptic vesicle dynamic changes in a model of fragile X.
Broek JAC; Lin Z; de Gruiter HM; van 't Spijker H; Haasdijk ED; Cox D; Ozcan S; van Cappellen GWA; Houtsmuller AB; Willemsen R; de Zeeuw CI; Bahn S
Mol Autism; 2016; 7():17. PubMed ID: 26933487
[TBL] [Abstract][Full Text] [Related]
37. Rescue of NMDAR-dependent synaptic plasticity in Fmr1 knock-out mice.
Bostrom CA; Majaess NM; Morch K; White E; Eadie BD; Christie BR
Cereb Cortex; 2015 Jan; 25(1):271-9. PubMed ID: 23968838
[TBL] [Abstract][Full Text] [Related]
38. BDNF in fragile X syndrome.
Castrén ML; Castrén E
Neuropharmacology; 2014 Jan; 76 Pt C():729-36. PubMed ID: 23727436
[TBL] [Abstract][Full Text] [Related]
39. Multiple autism-linked genes mediate synapse elimination via proteasomal degradation of a synaptic scaffold PSD-95.
Tsai NP; Wilkerson JR; Guo W; Maksimova MA; DeMartino GN; Cowan CW; Huber KM
Cell; 2012 Dec; 151(7):1581-94. PubMed ID: 23260144
[TBL] [Abstract][Full Text] [Related]
40. Aberrant differentiation of glutamatergic cells in neocortex of mouse model for fragile X syndrome.
Tervonen TA; Louhivuori V; Sun X; Hokkanen ME; Kratochwil CF; Zebryk P; Castrén E; Castrén ML
Neurobiol Dis; 2009 Feb; 33(2):250-9. PubMed ID: 19056494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
